Blogs | Multibagger Shares

April 29, 2026

Dark Blue Page Header with mr Market Title and Subtitle Followed by a Horizontal Bar Chart of Yearly Figures Fy20fy25 fy25 in Green Value 11

Mr. Market: Benjamin Graham’s 1949 Parable for Treating Daily Quotes as Offers, Not Verdicts

Benjamin Graham's 1949 Mr. Market parable is the operating system for ignoring daily price quotes. Titan Biotech FY25's audited quiet — ₹3 cr borrowings, 103% CFO/PAT, 36.4% ROCE — illustrates the underlying factory that survives every tick.

April 28, 2026

Hero Banner with Title Status quo Bias and Subtitle Followed by a 2x2 Color Grid Labeling Four Investor Mindsets Lucky grey Disciplined Investor green Confused light Grey Bias trapped orange

Status-Quo Bias: Samuelson & Zeckhauser’s 1988 Cognitive Anchor That Keeps Indian Investors Stuck in Regular MF Plans, Old Brokers and Drifting Allocations

Samuelson & Zeckhauser (1988) showed that decision-makers stick to existing options far more than rationality justifies. AMFI / SEBI data shows roughly half of equity MF AUM is still in Regular Plans 13+ years after Direct Plans launched. This post unpacks the bias, gives a structural fix, and uses Titan Biotech FY25's audited numbers to illustrate corporate anti-status-quo discipline. Educational case study only — not investment advice.

April 28, 2026

Bar Chart of Interest Coverage Ratio by Fiscal Year fy20fy25 Fy20 28 Fy21 26 Fy22 22 Fy23 18 Fy24 14 Fy25 11 Fy25 Bar Highlighted in Green

Interest Coverage Ratio: The 30-Second Solvency Filter

Interest Coverage Ratio (EBIT/Finance Costs) is the 30-second solvency filter every Indian value investor must know. Titan Biotech FY25's ~₹3 Cr borrowings, ₹11 Cr internally funded CWIP, and 103% CFO/Operating Profit illustrate what fortress-coverage looks like in numbers.

April 28, 2026

Dark Blue Hero Area with a Large White Title the Maximum Pessimism Rule and Green Subtitle a 2x2 Color Grid Shows Top left trader Top right compounder Bottom left drift Bottom right speculator

The Maximum Pessimism Rule: Sir John Templeton’s Contrarian Doctrine for Indian Value Investors

Sir John Templeton's 'buy at the point of maximum pessimism' rule is the most uncomfortable, most lucrative discipline in value investing. Here's how Indian value investors can apply it in 2026 — and why durable, debt-free compounders are the right business-side filter.